Amifostine Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with amifostine
D
- Demadex (torsemide)
- Demadex IV (torsemide)
- Demi-Regroton (chlorthalidone / reserpine)
- Demser (metyrosine)
- Deponit (nitroglycerin)
- deserpidine
- deserpidine / hydrochlorothiazide
- deserpidine / methyclothiazide
- Diaqua (hydrochlorothiazide)
- Diaqua-2 (furosemide)
- diazoxide
- Dibenzyline (phenoxybenzamine)
- Dilacor XR (diltiazem)
- Dilatrate-SR (isosorbide dinitrate)
- Dilt-XR (diltiazem)
- Diltia XT (diltiazem)
- diltiazem
- Diltiazem Hydrochloride CD (diltiazem)
- Diltiazem Hydrochloride SR (diltiazem)
- Diltiazem Hydrochloride XR (diltiazem)
- Diltiazem Hydrochloride XT (diltiazem)
- diltiazem / enalapril
- Diltzac (diltiazem)
- Diovan (valsartan)
- Diovan HCT (hydrochlorothiazide / valsartan)
- Diucardin (hydroflumethiazide)
- Diupres-250 (chlorothiazide / reserpine)
- Diupres-500 (chlorothiazide / reserpine)
- Diurese (trichlormethiazide)
- Diuretic Ap-Es (hydralazine / hydrochlorothiazide / reserpine)
- Diuril (chlorothiazide)
- Diuril Sodium (chlorothiazide)
- Diutensen-R (methyclothiazide / reserpine)
- Doxadura (doxazosin)
- doxazosin
- Duraclon (clonidine)
- dutasteride / tamsulosin
- Dutoprol (hydrochlorothiazide / metoprolol)
- Dyazide (hydrochlorothiazide / triamterene)
- Dynacirc (isradipine)
- DynaCirc CR (isradipine)
- Dyrenium (triamterene)
More about amifostine
- amifostine consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: antineoplastic detoxifying agents
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.